KR20150049082A - Skin composition comprising the extract of fermented chestnut bur for anti-wrinkle or anti-bacterial activity - Google Patents

Abstract

The present invention relates to a composition containing fermented chestnut bur extract as an active component, and more specifically, confirms anti-wrinkle, anti-bacterial activity, and astringent activity via tests including: an anti-wrinkle activity test such as Elastase inhibition activity, Collagenase inhibition activity, and others; an anti-bacterial test regarding strain such as Candida albicans, Escherichia coli, Staphylococcus epidermidis, Staphylococcus aureus, Propionibacterium acnes, and others; and a test for astringent effects using hemoglobin. Therefore, the composition can be efficiently used for anti-wrinkle, and for treatment and prevention of bacterial skin infections.

Description

[0001] The present invention relates to a skin-wrinkle-preventing and anti-bacterial composition containing an extract of fermented chestnut,

The present invention relates to a skin wrinkle preventing and antimicrobial composition containing an extract of fermented chestnut as an active ingredient.

[1] Voegeli, R. 1996. Elastase and typing determination on human skin surface. Cosmetic & Toiletries. 111, 51-58

[Literature 2] Aroca, P., et al. 1993. Melanin biosynthesis patterns of following hormonal stimulation. J. Biol Chem 268, 25650-25655

[Literature 3] Chin, J. E., et al. 2005. Effects of Houttuynia cordata extracts on tyrosinase gene expression. J. Korean Soc Food Sci Nutr 34, 1284-1288

[4] Oikarinen A, Karvonen J, Uitto J, and Hannuksela M., Connective tissue alterations in skin exposed to natural and therapeutic UV-radiation. Photodermatol . 2 (1) , pp. 15-26, Review, 1985.

[Literature 5] Hirobe T., Role of keratinocyte-derived factors involved in regulating the proliferation and differentiation of mammalian epidermal melanocytes. Pigment Cell Res . 18 (1) , pp.2-12. Review, 2005

[Literature 6] McKay IA, Leigh IM., Epidermal cytokines and their roles in cutaneous wound healing. Br J Dermatol. 124 (6) , pp.513-8, Review, 1991

[7] Kim HH, Cho S, Lee S, Kim KH, Cho KH, Eun HC, Chung JH, Photoprotective and anti-skin-aging effects of eicosapentaenoic acid in human skin in vivo. J Lipid Res . 47 (5) , pp.921-30, 2006

[8] Medina A, Ghaffari A, Kilani RT, Ghahary A., The role of stratifin in fibroblast-keratinocyte interaction. Mol Cell Biochem . 305 (1-2) , pp. 255-64, Review, 2007

[9] Wang XJ, Han G, Owens P, Siddiqui Y, Li AG., Role of TGF beta-mediated inflammation in cutaneous wound healing. J Investig Dermatol Symp Proc . 11 (1) , pp. 112-7, Review, 2006

[10] Traidl-Hoffmann C, MI, Ring J, Behrendt H., Impact of desloratadine and loratadine on the crosstalk between human keratinocytes and leukocytes: Implications for anti-inflammatory activity of antihistamines. Int Arch Allergy Immunol . 140 (4) , pp.315-20, 2006

[Document 11] Cannon JG, Tatro JB, Reichlin S, Dinarello CA., Alpha melanocyte stimulating hormone inhibits immunostimulatory and inflammatory actions of interleukin 1. J Immunol . 137 (7) , pp.2232-6, 1986

[12] Yamamoto T, Eckes B, Mauch C, Hartmann K, Krieg T., Monocyte chemoattractant protein-1 enhancer gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 alpha loop. J Immunol . 164 (12) , pp.6174-9, 2000

[13] Dai G, Freudenberger T, Zipper P, Melchior A, Grether-Beck S, Rabausch B, de Groot J, Twarock S, Hanenberg H, Homey B, Krutmann J, Reifenberger J, Fischer JW., Chronic ultraviolet B Hyaluronic acid synthase is the down-regulation of hyaluronic acid synthases. Am J Pathol . 171 (5) , pp.1451-61, 2007. 9-10

[Document 14] Willoughby DA. (1975) Human arthritis applied to animal models. Towards a beter therapy. Annals of the Rheumatic Disease . 34, 471-478

[Literature 15] Higuchi M, Hisgahi N, Taki H and Osawa T. (1990) Cytolytic mechanisms of activatged macrophages. Tumor necrosis factor and L-arginine-dependent mechanismsact synergistically as major cytolytic mechanisms of activated macrophages. The Journal of Immunology . 144, 1425-1431

[16] Yun HJ, Heo SK, Yi HS, Kim CH, Kim BW and Park SD. (2008) Anti-inflammatory effect of injinho-tang in Raw264.7 Cells. Kor . J. Herbology . 23 (2), 169-178

[Literature 17] Information Sourcing, Illustrated Essay, p806-808, Younglim, 1998

[Literature 18] Cannell RJP, Kellan SJ, Owsians AM and Walker JM. (1988) Results of a large scale screen of microalgae for the production of protease inhibitors. Planta Media . 54 (1), 10-14

[19] Van Wart HE, Steinbrink DR (1981), A continuous spectrophotometric assay for Clostridium histolyticum collagenase. Anal . Biochem ., 113 (2): 356-365

[20] An BJ, Kwak JH, Son JH, Park JM, Lee JY, Jo C., Byun MW (2004), Biological and anti-microbial activity of irradiated green tea polyphenols. Food Chemistry ., 88: 549555

[21] Lee, JT, Jeong, YS and An, BJ: Physiological activity of Salicornia herbacea and its application for cosmetic materials. Kor. J. Herbology, 17, 51-60, 2002.

Modern humans promote skin aging phenomena such as spots, freckles, and skin pigmentation by inducing various skin troubles due to various internal and external factors such as ultraviolet rays and stress. (1.Voegeli, R. 1996. Elastase and typing determination on human skin surface. Cosmetic & Toiletries. 111, 51-58.). Pigmentation of the skin is known to regulate the initial reaction from DOPA to DOPA quinone with tyrosinase enzyme, L-tyrosine, such as DHICA oxidase (TRP-1), and DOPA (3,4-dihydroxyphenyla-lanine) in melanin pigment biosynthesis (2.Aroca, P., et al., 1993. Melanin biosynthesis patterns of the following hormonal stimulation, J. Biol Chem 268, 25650-25655.). On the basis of this, studies on the search for natural products that inhibit the activity of tyrosinase enzyme and affect the inhibition of melanin biosynthesis are actively conducted. As a result, the tyrosinase gene expression inhibitory effect of Hwasungcho extract was investigated (Chin, JE, et al., 2005. Effects of Houttuynia cordata extracts on tyrosinase gene expression, J. Korean Soc Food Sci Nutr 34, 1284-1288. ) Are being actively studied. Other known antioxidative and whitening raw materials are Arbutin, Kojic acid, Ascorbic acid, etc. Plant extracts such as bark, mackerel and licorice are widely known.

In recent years, herbal medicines have been widely used regardless of product type and formulations as cosmetics having multiple functions such as whitening, anti-aging, skin improvement, anticancer and antibacterial function. In 1973, Amorepacific applied direct use of natural products to cosmetics. And it is said that it is a good idea to introduce the product called Jinsei Sangmi which is the main raw material. Mushrooms, green tea, burdock, mulberry, etc., and is actively utilizing it in the development of cosmetics. Currently, the world cosmetics market is growing by 10% annually from about $ 250 billion in 2005 It is evolving from simple cosmetics to disease treatment concept, expanding to multi-functionality with high functionality, changing to the era of oriental cosmetics In addition, The global market for natural functional materials has reached an annual sales value of $ 15 billion, with an annual average growth rate of over 10%. In the development of skin natural materials, it is expected that the annual sales of 1 trillion won ~ 2 trillion won and the profit of 20 ~ 50% of sales will be possible.

In particular, research on oriental herbs in the development of raw materials for wrinkle-improving cosmetics has become a mainstay of domestic cosmetics development in line with the development of raw materials based on our traditional medicine and the preference of cosmetics in Korea. And functional cosmetics are being developed in the direction of adding high functionality and versatility, and it is expected that the development of such functional materials and related technologies will become more active. It is not only effective protection of delicate skin after cosmetic molding and peeling, but also as a functional cosmetic product or quasi-drug due to excellent skin regeneration effect, it is worth the commercialization and development of skin new drug Can quickly determine the success of the development at the beginning of the clinical phase, thus reducing the risk of failure in the late phase of the clinical trial. In addition, since the period required for the development of new drugs is relatively short, the development of the skin disease can be made early and the investment can be recovered quickly, which will create a new paradigm for the development of new drugs.

The increase of ultraviolet rays and the increase of various oxidizing substances due to the destruction of the environment can cause skin damage and deterioration of the total performance of proteins. Such damage or deterioration of the skin cells causes a decrease in skin elasticity, an increase in skin wrinkles, and a lethal phenomenon in skin cosmetics such as stain and freckle formation. Skin elasticity is maintained by collagen, elastin, hyaluronic acid and the like of dermal tissue, and fibroblasts synthesizing collagen play a key role (Oikarinen A, Karvonen J, Uitto J, Hannuksela M., Photodermatol. 2 (1) , pp.15-26, Review, 1985.). Fibroblast function is regulated not only by various growth factors but also by cytokines secreted from skin cells such as keratinocytes and melanocytes (Hirobe T., Role of keratinocyte- derived factors involved in regulating the proliferation and differentiation of mammalian epidermal melanocytes. Pigment Cell Res. 18 (1) , pp.2-12. Review, 2005; McKay IA, Leigh IM., Epidermal cytokines and their roles in cutaneous wound healing. Br J Dermatol . 124 (6) , pp.513-8, Review, 1991.). TGF-β, TβRII, and SGad3 of keratinocytes liberated under normal conditions increase the expression of procollagen, fibrillin-1, and tropoelastin from dermal fibroblasts, resulting in collagen production , And suppression of collagen degradation by inhibiting the expression of MMPs (Kim HH, Cho S, Lee S, Kim KH, Cho KH, Eun HC and Chung JH, Photoprotective and anti-skin-aging effects of eicosapentaenoic acid acid in human skin in vivo. J Lipid Res . 47 (5) , pp.921-30, 2006; Medina A, Ghaffarie, Kilani RT, Ghahary A., The role of stratifin in fibroblast-keratinocyte interaction. Mol Cell Biochem . In addition to TGF-β (transforming growth factor), tumor necrosis factor (TNF-α), PGE ₂ (prostaglandin E ₂ ), α-MSH (melanocyte stimulating hormone), GSF (granulocyte stimulating factor), IL-1 (interleukin-1), IL-6, IL-8 and IL-10 XJ, Han G, Owens P, Siddiqui Y, Li AG., Role of TGF beta-mediated inflammation in cutaneous wound healing. J Investig Dermatol Symp Proc . 11 (1) , pp. 112-7, Review, 2006; Traidl-Hoffmann C, MI, Ring J, Behrendt H., Impact of desloratadine and loratadine on the crosstalk between human keratinocytes and leukocytes: Implications for anti-inflammatory activity of antihistamines. Int Arch Allergy Immunol . 140 (4) , pp.315-20, 2006.). Both α-MSH and PGE ₂ stimulate melanocytes to promote melanogenesis, which enhances the antioxidant action of skin cells and prevents skin cells from being damaged by ultraviolet rays (Cannon JG, Tatro JB, Reichlin S, Dinarello CA., Alpha melanocyte stimulating hormone inhibits immunostimulatory and inflammatory actions of interleukin 1. J Immunol . 137 (7) , pp.2232-6, 1986.). IL-1 and TNF-α (tumor necrosis factor) act on fibroblasts to inhibit procollagen expression and inhibit MMP-1 (martrix metalloproteinase-1), MMP-2, MMP-3, hyaluronidase And the collagen degradation is promoted (Yamamoto T, Eckes B, Mauch C, Hartmann K, Krieg T., Monocyte chemoattractant protein-1 enhancer gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL .. -1 alpha loop J Immunol 164 (12), pp.6174-9, 2000; Dai G, Freudenberger T, Zipper P, Melchior A, Grether-Beck S, Rabausch B, de Groot J, Twarock S, Hanenberg H , Homey B, Krutmann J, Reifenberger J, Fischer JW., Chronic ultraviolet B irradiation causes loss of hyaluronic acid from mouse dermis because of down-regulation of hyaluronic acid synthases. Am J Pathol . 171 (5) , pp.1451-61 , 2007. 9-10). In addition, even if fibroblast is directly injured by UV, the collagen-related gene is suppressed and the expression of MMPs related to degradation is promoted and the wrinkles are increased. Thus, increasing the proliferation and collagen synthesis of dermal fibroblasts, or inhibiting MMPs, may be a means of inhibiting the formation of wrinkles.

Inflammation is a mechanism to repair and regenerate the injured area when an invasion that causes any physical change such as physical action, chemical substance, or bacterial infection is applied to a living body or tissue. Once the stimulation is applied, the vasoactive substance such as inflammatory component is released locally and the vascular permeability is increased to cause inflammation. However, the continuous inflammatory reaction promotes the mucosal injury, and as a result, it causes some diseases [Willoughby. (1975) Human arthritis applied to animal models. Towards a beter therapy. Annals of the Rheumatic Disease . 34, 471-478.]. It is known that macrophages are involved in various host responses such as acquired immunity as well as innate immunity, and they play an important role in biological defense in the early stage of infection by producing nitric oxide (NO) and cytokine in the inflammatory reaction [ Higuchi M, Hisgahi N, Taki H and Osawa T. (1990) Cytolytic mechanisms of activatged macrophages. Tumor necrosis factor and L-arginine-dependent mechanismsact synergistically as major cytolytic mechanisms of activated macrophages. The Journal of Immunology . 144, 1425-1431.]. In the case of nitric oxide synthase (NOS) in mammalian cells, there are three similar forms: neuronal NOS (nNOS), endothelial NOS (eNOS), and inducible NOS (iNOS). Among them, iNOS is involved in the inflammatory reaction. nNOS and eNOS are expressed at all times, and iNOS is expressed when interferon-γ, lipopolysaccharide (LPS) and various inflammatory cytokines are stimulated. NO also controls acute, chronic inflammatory reactions. PGE ₂ is produced from arachidonic acid by cyclooxygenase (COX). COX was mainly studied in the early 1990s, which also has two similar forms. COX-1 is expressed in almost all tissues and produces prostaglandins to regulate physiological functions such as regulating blood flow to the kidneys and protecting gastrointestinal cells. Conversely, COX-2 is expressed in macrophages that respond to microbial infection or damage or stress of various factors. In other words, expression of iNOS and COX-2 and NO and PGE2 are typical inflammatory factors of immune cells. The proinflammatory cytokines such as tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), monocyte chemoattractant protein- [Yun HJ, Heo SK, Yi HS, Kim CH, Kim BW and Park SD. (2008) Anti-inflammatory effect of injinho-tang in Raw264.7 Cells. Kor . J. Herbology . 23 (2), 169-178.

Chestnut is a deciduous tree belonging to Fagaceae. Chestnut fruit is used as food in the form of chestnut and is composed of protein, starch, fat, carbohydrate, inorganic components, lipase The leaves are called 栗 葉, the flowers are called 栗 花, the chestnuts are chestnut; The chestnut is called chestnut, and it has been mainly used in the private sector for diarrhea, bloody stools, asthma, fractures, etc. (Information, Interpretation of Diagrams, p806-808, Yeonglim, 1998).

The chestnut produced by manual processing in chestnut is a by-product, which is not developed for industrial use. Most of it is disposed of and it is recycled by researching various pharmacological activities against boson in terms of environment protection and by- It is expected to make a great contribution both industrially and environmentally.

Therefore, the present inventors have conducted experiments on wrinkle-improving activity such as inhibition of elastase and inhibition of collagenase in fermented Blythgrass extracts; For example, Candida albicans, Escherichia coli, Staphylococcus epidermidis, Staphylococcus aureus, Propionibacterium acnes, and the like. Antimicrobial activity and convergent activity through experiments on antimicrobial activity against bacteria and hemoglobin, and thus it is found that the composition of the present invention is useful as a composition for treating and preventing wrinkles and bacterial skin diseases .

In order to accomplish the above object, the present invention provides a dermatological pharmaceutical composition for treating and preventing wrinkles and bacterial skin diseases, which comprises fermented chestnut extract as an active ingredient.

In order to achieve the above object, the present invention provides a cosmetic composition for improving wrinkles and prevention and improvement of bacterial skin diseases, which comprises fermented Blythei extract as an active ingredient.

As used herein, the term " extract " includes fermented Bacillus supernatant and precipitate extract, and specifically includes water, ethanol, methanol, propanol, butanol, acetone, ethyl acetate, hexane, butylene glycol, propylene glycol, At least one solvent selected from the group consisting of propylene glycol, propylene glycol, and functional glycerin, preferably water or a mixture of water and ethanol, most preferably 60% to 80% ethanol soluble extract.

Bacterial skin diseases as defined herein include, but are not limited to, Candida albicans, Escherichia coli, Staphylococcus epidermidis, Staphylococcus aureus, Acne, oral infection, genital infections, purulent skin, ear infections, otitis media, cystitis, and more preferably acne. The present invention also relates to a method for treating a skin disease caused by a strain such as Propionibacterium acnes.

Wherein the fermented chestnut extract comprises 0.1 to 50% by weight based on the total weight of the skin pharmaceutical composition.

The pharmaceutical composition includes a cream, a gel, a patch, a spray, an ointment, an alarm, a lotion, a liniment, a pasta or a cataplasmal formulation.

In addition, the cosmetic composition includes formulations of lotion, skin, lotion, nutrition lotion, nutritional cream, massage cream, essence, and pack.

As defined herein, the chestnut is selected from the group consisting of Castanea crenata, Castanea mollissima, Castanea davidii, China, Castanea henryi, Castanea seguinii, mountain; Castanea dentata, Castanea pumila, Castanea alnifolia, Castanea ashei, Castanea floridana, Castanea paupispina, and the like , And Castanea sativa (Castanea sativa).

Said fermentation defined herein are active via a liquid culture of lactic acid bacteria, preferably lactic acid bacteria, more preferably, Lactobacillus bacteria (Lactobacillus) are in the strain, more preferably, Lactobacillus casei (Lactobacillus casei,) L. gasseri, L. bulgaricus, L. bifermentans, L. brevis, L. agilis, Lactobacillus spp., Lactobacillus sp. L. kefir, L. amylophillus, L. acidophilus, L. bavarius, Lactobacillus lambosus (Lactobacillus amylophilus), Lactobacillus amyloptilus L. rhamnosus, L. fermentum, L. helveticus, L. johnsonil, L. paracasei, Lactobacillus planta, Lactobacillus plantarum, Lactobacillus plantarum, More preferably at least one strain selected from the group consisting of L. plantarum, L. reuteri and L. salivarius, more preferably Lactobacillus casei, Lactobacillus casei, Lactobacillus casei, Lactobacillus casei, ) One or more strains selected from the group consisting of L. gasseri and L. bulgaricus are used in an amount of 1-30% (v / v), preferably 1-10% (v / v) v / v) at a temperature in the range of 15 to 50 DEG C, preferably 20 to 40 DEG C for 1 day to 2 weeks, preferably 2 days to 6 days, more preferably 36 hours to 56 Followed by subculturing to obtain the fermented bison of the present invention.

More specifically, the liquid culture defined herein is a mixed liquid medium, preferably 10 to 30.0 g / l Sucrose, 1 to 10.0 g / l Glucose, 3 to 20.0 g / l Soypeptone, 1 to 100 yeast extract 1 to 5.0 g / l of K ₃ COONa, 0.1 to 0.6 g / l of K ₂ HPO ₄ and 0.01 to 0.05 g / l of MgCl ₂ , preferably 20.0 to 25.0 g / l of Sucrose, 3.0 to 25.0 g / 7.0 g / l, Soypeptone 8.0 to 15.0 g / l, Yeast extract 1.0 to _{8.0 g / l, CH 3 COONa} 1.0 to _{3.0 g / l, K 2 HPO} 4 0.1 to 0.3 g / l, and MgCl ₂ 0.01 to 0.04 g / l range is adjusted to pH 4.00 to 7.00, preferably pH 5.5 to pH 6.50, followed by sterilization to perform fermentation.

Specifically, a method for producing the fermented extract of the present invention will be described.

For example, fermentation extract of the present invention is a sticker material of the cleaning and dry the liquid culture the through the active lactic acid bacteria, preferably lactic acid bacteria, more preferably, Lactobacillus bacteria (Lactobacillus) in the strain, and even more preferably, Lactobacillus Lactobacillus casei , ) L. gasseri, L. bulgaricus, L. bifermentans, L. brevis, L. agilis, Lactobacillus spp., Lactobacillus sp. L. kefir, L. amylophillus, L. acidophilus, L. bavarius, Lactobacillus lambosus (Lactobacillus amylophilus), Lactobacillus amyloptilus L. rhamnosus, L. fermentum, L. helveticus, L. johnsonil, L. paracasei, Lactobacillus planta, Lactobacillus plantarum, Lactobacillus plantarum, Room (L. plantarum), Lactobacillus low Terry (L. reuteri), and Lactobacillus salivarius (L. salivarius) in one or more strains selected from the group, more preferably, Lactobacillus casei (Lactobacillus than configured casei , ) One or more strains selected from the group consisting of L. gasseri and L. bulgaricus are used in an amount of 1-30% (v / v), preferably 1-10% (v / v) v / v) at a temperature in the range of 15 to 50 DEG C, preferably 20 to 40 DEG C for 1 day to 2 weeks, preferably 2 days to 6 days, more preferably 36 hours to 56 Culturing for a period of time to obtain a fermented bison; Ethanol, methanol, propanol, butanol, acetone, ethyl acetate, hexane, butylene glycol, propylene glycol, butyl methyl ether, methyl ethyl ketone, methyl isobutyl ketone, Preferably 60 to 80% ethanol by adding at least one solvent selected from the group consisting of propylene glycol, propylene glycol, glycerol, propylene glycol, and glycerin, preferably water or a mixture of water and ethanol, most preferably 60 to 80% ethanol, The extraction method such as hot water extraction, cold extraction, reflux cooling extraction or ultrasonic extraction is preferably used for cold extraction at 80 to 80 ° C for about 1 to 14 days, preferably 2 to 6 days, ; The fermented Bacillus supernatant and the precipitate extract of the present invention can be obtained through filtration of the extract solution, classification into a supernatant and a precipitate, respectively, and a third step of filtration and concentration thereof, respectively.

The present invention provides a pharmaceutical composition for external use for skin and a cosmetic composition having anti-wrinkle effect and antimicrobial effect, which comprises the fermented balsam extract obtained by the above production method and the above-mentioned production method as an active ingredient.

The inventors of the present invention conducted experiments for improving wrinkles such as Elastase inhibitory activity and Collagenase inhibitory activity against the fermented Blythgrass extract of the present invention; For example, Candida albicans, Escherichia coli, Staphylococcus epidermidis, Staphylococcus aureus, Propionibacterium acnes, and the like. Antimicrobial activity and convergent activity through experiments such as antimicrobial activity on strains and convergence effect using blood proteins (hemoglobin), it was confirmed that it is useful as a composition for treating wrinkles and treating and preventing bacterial skin diseases.

In addition, the chestnut has been used for a long time as herbal medicine and food, and the fermented chestnut extract of the present invention extracted therefrom has no problems such as toxicity and side effects, and since it has proved to be a non-irritant sample in skin patch test, Can be used.

The dermatological pharmaceutical composition containing the fermented chestnut extract of the present invention is prepared by a pharmaceutical composition in the form of a cream, a gel, a patch, a spray, an ointment, a warning agent, a lotion agent, a liniment agent, a pasta agent or a skin external preparation But is not limited thereto.

The preferred dosage of the fermented chestnut extract of the present invention varies depending on the condition and the weight of the patient, the degree of disease, the type of drug, the route of administration and the period of time, but can be appropriately selected by those skilled in the art. However, for the desired effect, the fermented chestnut extract of the present invention is preferably administered at a daily dose of 0.0001 to 100 mg / kg, preferably 0.001 to 10 mg / kg. The administration may be carried out once a day or divided into several times. The dose is not intended to limit the scope of the invention in any way.

The fermented chestnut extract of the present invention can be used variously in cosmetics and cleansers having a whitening effect.

Examples of products to which the present composition can be added include cosmetics such as lotion, skin, lotion, nutrition lotion, nutritional cream, massage cream, essence, pack, cleansing, cleanser, soap, have.

The cosmetic composition of the present invention comprises a composition selected from the group consisting of water-soluble vitamins, oil-soluble vitamins, high molecular weight peptides, polymeric polysaccharides, sphingolipids and seaweed extracts.

The water-soluble vitamin is not particularly limited as long as it can be compounded in cosmetics. Preferably, vitamin B, vitamin B2, vitamin B6, pyridoxine, pyridoxine hydrochloride, vitamin B12, pantothenic acid, nicotinic acid, nicotinic acid amide, folic acid, vitamin C, And their salts (thiamine hydrochloride, sodium ascorbate, etc.) or derivatives (sodium ascorbic acid-2-phosphate, magnesium ascorbate-2-phosphate etc.) can also be added to water-soluble vitamins . The water-soluble vitamin can be obtained by a conventional method such as a microorganism conversion method, a purification method from a culture of a microorganism, an enzymatic method, or a chemical synthesis method.

Usable vitamins include vitamins such as vitamin A, carotene, vitamin D2, vitamin D3, vitamin E (d1-alpha tocopherol, d-alpha tocopherol, d-alpha tocopherol) , Derivatives thereof (such as palmitic acid ascorbin, stearic acid ascorbic acid, dipalmitic acid ascorbin, dl-alpha tocopherol acetic acid, dl-alpha tocopherol nicotinic acid vitamin E, dl-pantothenyl alcohol, D-pantothenyl alcohol, Ether, etc.) are also included in the usable vitamins used in the present invention. Usability Vitamins can be obtained by a conventional method such as a microorganism conversion method, a purification method from a culture of a microorganism, an enzyme or a chemical synthesis method.

The polymeric peptide may be any compound as long as it can be compounded in cosmetics, and examples thereof include collagen, hydrolyzed collagen, gelatin, elastin, hydrolyzed elastin, and keratin. The polymeric peptide can be obtained by a conventional method such as purification from a culture broth of a microorganism, an enzymatic method, or a chemical synthesis method, or it can be purified from natural products such as ducks such as pigs and cows and silk fiber of silkworms.

The polymeric polysaccharide may be any compound as long as it can be incorporated in cosmetics, and examples thereof include hydroxyethyl cellulose, xanthan gum, sodium hyaluronate, chondroitin sulfate or a salt thereof (sodium salt, etc.). For example, chondroitin sulfate or a salt thereof can be usually purified from mammals or fish.

Sphingo lipids may be any as long as they can be incorporated into cosmetics, and preferable examples thereof include ceramides, phytosphingosine and sphingoglycolipids. Sphingoid lipids can be purified from ordinary mammals, fish, shellfish, yeast or plants by conventional methods or can be obtained by chemical synthesis.

The seaweed extract may be any of those which can be compounded in cosmetics. Preferably, the seaweed extract is selected from the group consisting of algae extract, red pepper extract, green algae extract and the like. Also, the algae extract may be colored guanine, arginic acid, Potassium alginate and the like are also included in the seaweed extract used in the present invention. Seaweed extract can be obtained from seaweed by a conventional method.

The cosmetic of the present invention may be blended with other essential ingredients, if necessary, in combination with the essential ingredients.

Examples of the compounding ingredients that may be added include organic solvents such as a preservative component, a moisturizer, an emollient, a surfactant, an organic and inorganic pigment, an organic powder, an ultraviolet absorbent, a preservative, a bactericide, an antioxidant, a plant extract, a pH adjuster, A blood circulation accelerator, a cold agent, an antiperspirant agent, and purified water.

Examples of the oil retaining component include ester-based oil retaining, hydrocarbon-based oil retaining, silicone-based oil retaining, fluoric oil retaining, animal retention and plant retention.

Examples of ester-based fats include glyceryl tri-2-ethylhexanoate, cetyl 2-ethylhexanoate, isopropyl myristate, butyl myristate, isopropyl palmitate, ethyl stearate, octyl palmitate, isostearyl isostearate, Butyl isopropyl myristate, isopropyl myristate, isopropyl myristate, isopropyl myristate, isopropyl myristate, isopropyl myristate, butyl, ethyl linoleate, isopropyl linoleate, ethyl oleate, isosilyl myristate, isostearic acid isostearyl, isostearyl palmitate, octyldodecyl myristate, Trimethylol propane, triisostearic acid trimethylol propane, tetra 2-ethylhexanoic acid pentaerythritol tetra (2-ethylhexanoate) , Decyl caprylate, decyl laurate, hexyl laurate, myristate decyl, myristyl myristate, myristine monoethyl stearate, stearyl stearate, decyl oleate, ricinoleic acid tri , Isostearyl stearate, isostearyl stearate, isodecyl stearate, octyldodecyl oleate, octyldodecyl linoleate, isopropyl isostearate, isopropyl stearate, isopropyl stearate, isopropyl stearate, -Hexyl stearate, stearyl ethylhexanoate, stearyl 2-ethylhexanoate, hexyl isostearate, ethylene glycol dioctanoate, ethylene glycol dioleate, propylene glycol dicaprate, di (capryl, capric acid) propylene glycol, Propyleneglycol propionate, propyleneglycol propionate, dicaproic acid neopentyl glycol, dioctanoic acid neopentyl glycol, tricarboxylic acid glyceryl, triunsaturated glyceryl, triisopalmitic acid glyceryl, triisostearic acid glyceryl, neopentanoic acid octyldodecyl Octanoic acid octanoate, octanoic acid octanoate, octanoic acid octanoate, octanoic acid octanoate, octanoic acid octanoate, octanoic acid octanoate, Octyldecyl lactate, octyldecyl lactate, octyldecyl lactate, polyglycerin oleic acid ester, polyglycerin isostearic acid ester, triisocetyl citrate, triisobutyl citrate, triisooctyl citrate, lauryl lactate, myristyl lactate, But are not limited to, ethyl, acetyltriethyl citrate, acetyltributyl citrate, trioctyl citrate, diisostearyl malate, 2-ethylhexyl hydroxystearate, di-2-ethylhexyl succinate, diisobutyl adipate, diisopropyl sebacate, But are not limited to, dioctyl sebacate, stearic acid cholesteryl, isostearic acid cholesteryl, hydroxystearic acid cholesteryl, oleic acid cholesteryl, oleic acid dihydrocholesteryl, isostearic acid pitostearyl, Stearoyl hydroxystearic acid isostearyl, 12-stearoyl stearyl hydroxystearate, 12-stearo And monohydroxystearic acid and esters such as sostearyl.

Examples of the hydrocarbon hydrocarbon-based fats include hydrocarbon fats and oils such as squalene, liquid paraffin, alpha-olefin oligomer, isoparaffin, ceresin, paraffin, floating isoparaffin, polybutene, microcrystalline wax and vaseline.

Examples of silicone based oils include polymethyl silicone, methylphenyl silicone, methyl cyclopolysiloxane, octamethylpolysiloxane, decamethylpolysiloxane, dodecamethylcyclosiloxane, dimethylsiloxane-methylcetyloxysiloxane copolymer, dimethylsiloxane-methylstarchoxysiloxane copolymer, alkyl Modified silicone oils, and amino-modified silicone oils.

Examples of the fluorine-based oil include perfluoropolyether and the like.

Examples of animal or vegetable oils include avocado oil, almond oil, olive oil, sesame oil, rice bran oil, new flower oil, soybean oil, corn oil, rape oil, apricot kernel oil, palm kernel oil, palm oil, castor oil, , Corn oil, palm oil, palm oil, cucumber nut oil, wheat germ oil, rice germ oil, shea butter, coltsfoot colostrum, marker daisy nut oil, mead home oil, egg oil, , Canned wax, carnauba wax, liquid lanolin, hardened castor oil, and the like.

Examples of the moisturizing agent include water-soluble low-molecular moisturizing agents, oil-soluble molecular moisturizing agents, water-soluble polymers, and oil-soluble polymers.

Examples of the water-soluble low-molecular moisturizing agent include serine, glutamine, sorbitol, mannitol, sodium pyrrolidone-carboxylate, glycerin, propylene glycol, 1,3-butylene glycol, ethylene glycol, polyethylene glycol B Glycol (polymerization degree n = 2 or more), polyglycerin B (polymerization degree n = 2 or more), lactic acid, lactic acid salt and the like.

Examples of the lipid-soluble low-molecular moisturizing agent include cholesterol and cholesterol ester.

Examples of the water-soluble polymer include carboxyvinyl polymer, polyaspartic acid, tragacanth, xanthan gum, methylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, carboxymethylcellulose, water-soluble chitin, chitosan, dextrin, etc. .

Examples of the oil-soluble polymer include polyvinylpyrrolidone / eicosene copolymer, polyvinylpyrrolidone / hexadecene copolymer, nitrocellulose, dextrin fatty acid ester, and polymer silicone.

Examples of the emollients include long chain acyl glutamic acid cholesteryl ester, hydroxystearic acid cholesteryl, 12-hydroxystearic acid, stearic acid, rosin acid and lanolin fatty acid cholesteryl ester.

Examples of the surfactant include nonionic surfactants, anionic surfactants, cationic surfactants, and amphoteric surfactants.

Examples of the nonionic surfactant include self emulsifying monostearate glycerin, propylene glycol fatty acid ester, glycerin fatty acid ester, polyglycerin fatty acid ester, sorbitan fatty acid ester, POE (polyoxyethylene) sorbitan fatty acid ester, POE sorbit fatty acid ester, POE (Polyoxyethylene / polyoxypropylene) copolymer, POE.POP alkyl ether, polyether-modified silicone, polyether-modified silicone, polyoxyethylene-polyoxypropylene (POE) Alkanolamides, alkylamine oxides, hydrogenated soybean phospholipids, and the like.

Examples of the anionic surfactant include fatty acid soap, alpha-acylsulfonate, alkylsulfonate, alkylarylsulfonate, alkylnaphthalenesulfonate, alkylsulfate, POE alkyl ether sulfate, alkylamide sulfate, alkyl phosphate, POE alkyl ginseng salt, Alkylsulfosuccinic acid salts, acylated hydrolyzed collagen peptide salts, and perfluoroalkyl phosphoric acid esters, and the like can be mentioned. have.

Examples of the cationic surfactant include alkyl trimethyl ammonium chloride, stearyl trimethyl ammonium chloride, stearyl trimethyl ammonium bromide, cetostearyl trimethyl ammonium chloride, distearyl dimethyl ammonium chloride, stearyl dimethyl benzyl ammonium chloride, behenyl trimethyl ammonium chloride, Benzalkonium, diethylaminoethylamide stearate, dimethylaminopropylamide stearate, quaternary ammonium salts of lanolin derivatives, and the like.

Examples of the amphoteric surfactant include carboxybetaine type, amide betaine type, sulfobetaine type, hydroxysulfobetaine type, amidosulfobetaine type, phosphobetaine type, aminocarboxylate type, imidazoline derivative type and amide amine type Amphoteric surfactants and the like.

Examples of the organic and inorganic pigments include inorganic pigments such as silicic acid, silicic anhydride, magnesium silicate, talc, sericite, mica, kaolin, Bengala, clay, bentonite, titanium mica, titanium oxide, bismuth chloride, zirconium oxide, magnesium oxide, Inorganic pigments such as calcium sulfate, barium sulfate, magnesium sulfate, calcium carbonate, magnesium carbonate, iron oxide, chromium oxide, chromium oxide, chromium hydroxide, But are not limited to, polyamide, polyester, polypropylene, polystyrene, polyurethane, vinyl resin, urea resin, phenol resin, fluororesin, silicon resin, acrylic resin, melamine resin, epoxy resin, polycarbonate resin, Silk powder, cellulose, CI Pigment Yellow, CI Pigment Orange, and composite pigments of inorganic pigments and organic pigments thereof.

As the organic powder, metallic soap such as calcium stearate; Metal salts of alkyl phosphates such as sodium zinc cetylate, zinc laurylate and calcium lauryl laurate; Acylamino acid polyvalent metal salts such as N-lauroyl-beta-alanine calcium, N-lauroyl-beta-alanine zinc and N-lauroylglycine calcium; Amidosulfonic acid multivalent metal salts such as N-lauroyl-taurine calcium and N-palmitoyl-taurine calcium; Such as N-epsilon-lauroyl-L-lysine, N-epsilon-palmitoylidene, N-alpha-paratyylnitine, N-alpha-lauroyl arginine, Acyl basic amino acids; N-acylpolypeptides such as N-lauroylglycylglycine; Alpha-amino fatty acids such as alpha-aminocaprylic acid, alpha-aminoaurauric acid, and the like; Polyethylene, polypropylene, nylon, polymethylmethacrylate, polystyrene, divinylbenzene-styrene copolymer, ethylene tetrafluoride, and the like.

Examples of ultraviolet absorbers include paraaminobenzoic acid, ethyl parnamobenzoate, amyl paranobenzoate, octyl paranobenzoate, ethyleneglycol salicylate, phenyl salicylate, benzyl salicylate, benzyl salicylate, butylphenyl salicylate, homomenthyl salicylate, benzyl cinnamate , Octyl methoxycinnamate, dioctyl methoxycinnamate, mono-2-ethylhexane glyceryl dipyrromethoxycinnamate, isopropyl paratumoxycinnamate, diisopropyl-diisopropyl cinnamate ester mixture, Carninoic acid, ethyl urocanoate, hydroxymethoxybenzophenone, hydroxymethoxybenzophenone sulfonic acid and salts thereof, dihydroxymethoxybenzophenone, sodium dihydroxymethoxybenzophenone disulfonate, dihydroxybenzophenone , Tetrahydroxybenzophenone, 4- tert -butyl-4'-methoxydibenzoylmethane, 2,4,6-trianylino- p- (carbo-2'-ethylhexyl-1'- , 3,5-triazine, 2- (2- And the like can be mentioned hydroxy-5-methylphenyl) benzotriazole.

Examples of the disinfectant include hinokitiol, trichloroacid, trichlorohydroxydiphenyl ether, crohexidine gluconate, phenoxyethanol, resorcin, isopropylmethylphenol, azulene, salicylic acid, zinc filitione, benzalkonium chloride, No. 301, mononitro and eicol sodium, and undecylenic acid.

Examples of the antioxidant include butylhydroxyanisole, gallic acid propyl, and eicosorbic acid.

Examples of the pH adjuster include citric acid, sodium citrate, malic acid, sodium malate, fumaric acid, sodium fumarate, succinic acid, sodium succinate, sodium hydroxide, sodium monohydrogenphosphate and the like.

Examples of the alcohol include higher alcohols such as cetyl alcohol.

In addition, any of the above components may be blended within the range not to impair the objects and effects of the present invention, but it is preferably 0.01 to 5% by weight based on the total weight, Preferably 0.01 to 3% by weight.

The cosmetic of the present invention may take the form of a solution, an emulsion, a viscous mixture or the like.

The ingredients contained in the cosmetic composition of the present invention may contain, as an active ingredient, the ingredients commonly used in cosmetic compositions in addition to the above-mentioned fermented bean curd extract, for example, stabilizers, solubilizers, vitamins, pigments, Phosphorus auxiliaries and carriers.

The cosmetic composition of the present invention can be prepared into any formulation conventionally produced in the art, and examples thereof include emulsions, creams, lotions, packs, foundations, lotions, essences, and hair cosmetics.

Specifically, the cosmetic composition of the present invention can be used as a skin lotion, a skin softener, a skin toner, an astringent, a lotion, a milk lotion, a moisturizing lotion, a nutrition lotion, a massage cream, a nutrition cream, a moisturizing cream, a hand cream, Packs, soaps, cleansing foams, cleansing lotions, cleansing creams, body lotions and body cleansers.

When the formulation of the present invention is a paste, cream or gel, animal fiber, plant fiber, wax, paraffin, starch, tracant, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be used as the carrier component .

When the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component. In the case of a spray, in particular, / Propane or dimethyl ether.

In the case of the solution or emulsion of the present invention, a solvent, a solvent or an emulsifier is used as a carrier component, and examples thereof include water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, , 3-butyl glycol oil, glycerol aliphatic ester, polyethylene glycol or sorbitan fatty acid esters.

When the formulation of the present invention is a suspension, a carrier such as water, a liquid diluent such as ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, Cellulose, aluminum metahydroxide, bentonite, agar or tracant, etc. may be used.

When the formulation of the present invention is an interfacial active agent-containing cleansing, the carrier component may include aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyltaurate, sarcosinate, fatty acid amide Ether sulfates, alkylamidobetaines, aliphatic alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, linolenic derivatives or ethoxylated glycerol fatty acid esters.

The fermented chestnut extract of the present invention is an activity of improving wrinkles such as an elastase inhibitory activity and a collagenase inhibitory activity; For example, Candida albicans, Escherichia coli, Staphylococcus epidermidis, Staphylococcus aureus, Propionibacterium acnes, and the like. Antimicrobial activity and convergent activity through experiments such as antimicrobial activity against strains and convergence effect using blood proteins (hemoglobin), thereby being useful as a composition for treating wrinkles and treating and preventing bacterial skin diseases .

Brief Description of the Drawings Fig. 1 is a graph showing changes in the number of viable cells according to fermentation conditions of fermented chestnut;
FIG. 2 is a graph showing the pH change according to the fermentation conditions of the fermented chestnut;
FIG. 3 is a graph showing the inhibitory activity of the fermented chestnut extract against elastase (where A is Lactobacillus casei (0%), fermented after 1 day fermentation and B is Lactobacillus casei (1% C is a fermented chestnut extract of Lactobacillus casei (5%) after fermentation for 1 day, D is a fermented chestnut extract of Lactobacillus casei (10%) after 1 day fermentation, and E is Lactobacillus casei (0%) 3 days after fermentation fermentation sticker extract and; F is Lactobacillus casei (1%) and the fermentation sticker extract 3 days after fermentation; G is a fermentation sticker extract 3 days after fermentation by Lactobacillus casei (5%); H is Lactobacillus casei ( 10%); I is Lactobacillus casei (0%), fermented chestnut extract after 6 days fermentation; J is Lactobacillus casei (1%) fermented chestnut extract after 6 days fermentation; K (5%) of Lactobacillus casei after 6 days of fermentation. L is Lactobacillus casei (10%), fermented chestnut extract after 6 days of fermentation; AA: Ascorbic acid, and the result is the means (± SD) of triplicate);
FIG. 4 is a graph showing collagenase inhibitory activity of the fermented chestnut extract (wherein A is Lactobacillus casei (0%) after 1 day of fermentation; B is Lactobacillus casei (1%) and fermented after 1 day fermentation; C is Lactobacillus casei (5%) and fermented after 1 day fermentation; D is Lactobacillus casei (10%) and fermented after 1 day fermentation; E is Lactobacillus casei (0%) and fermented after 3 days of fermentation; F is fermented chestnut extract after 3 days fermentation with Lactobacillus casei (1%); G is a fermented chestnut extract after 3 days fermentation with Lactobacillus casei (5%); H is a fermented chestnut extract after 3 days fermentation with Lactobacillus casei (10%); I is a fermented chestnut extract after 6 days fermentation with Lactobacillus casei (0%); J is a fermented chestnut extract after 6 days fermentation with Lactobacillus casei (1%); K is Lactobacillus casei (5%) and fermented after 6 days of fermentation; L is Lactobacillus casei (10%) and fermented after 6 days of fermentation; AA: Ascorbic acid, and the result is the mean (means) SD of triplicate);
Figure 5 is a diagram showing the antimicrobial activity of Escherichia coli of fermented chestnut extract, wherein A is Lactobacillus casei (0%) after 1 day of fermentation; B is Lactobacillus casei (1%) and fermented after 1 day fermentation; C is Lactobacillus casei (5%) and fermented after 1 day fermentation; D is Lactobacillus casei (10%) and fermented after 1 day fermentation; E is Lactobacillus casei (0%) and fermented after 3 days of fermentation; F is fermented chestnut extract after 3 days fermentation with Lactobacillus casei (1%); G is a fermented chestnut extract after 3 days fermentation with Lactobacillus casei (5%); H is a fermented chestnut extract after 3 days fermentation with Lactobacillus casei (10%); I is a fermented chestnut extract after 6 days fermentation with Lactobacillus casei (0%); J is a fermented chestnut extract after 6 days fermentation with Lactobacillus casei (1%); K is Lactobacillus casei (5%) and fermented after 6 days of fermentation; L is Lactobacillus casei (10%) and fermented after 6 days of fermentation; AA: Ascorbic acid, and the result is the mean (means) SD of triplicate);
Figure 6 shows the antimicrobial activity against Staphylococcus epidermidis of the fermented chestnut extract, wherein A is a fermented chestnut extract after 1 day fermentation with Lactobacillus casei (0%); B is Lactobacillus casei (1%), fermented chestnut extract after 1 day fermentation; C is Lactobacillus casei (5%) fermented after 1 day of fermentation; D is Lactobacillus casei (10%) fermented after 1 day fermentation; E is Lactobacillus casei (0%) after fermentation for 3 days, F is a fermented chestnut extract, L is Lactobacillus casei (1%) after fermentation for 3 days; G is Lactobacillus casei (5%) after fermentation for 3 days; H is Lactobacillus casei (10%) after fermentation for 3 days; I is Lactobacillus casei (0%), fermented after fermentation for 6 days; J is a fermented chestnut extract after 6 days fermentation with Lactobacillus casei (1%); K is Lactobacillus casei (5%) and fermented after 6 days of fermentation; L is Lactobacillus casei (10%) and fermented after 6 days of fermentation; AA: Ascorbic acid, and the result is the mean (means) SD of triplicate);
Figure 7 shows the antimicrobial activity against Staphylococcus aureus of fermented chestnut extract (wherein A is Lactobacillus < RTI ID = 0.0 > casei (0%) after 1 day of fermentation; B is Lactobacillus Casei (1%) was fermented chestnut extract after 1 day fermentation. C was Lactobacillus casei (5%) fermented after 1 day fermentation, and D was Lactobacillus casei (10% E was fermented chestnut extract after 3 days fermentation with Lactobacillus casei (0%), F was Lactobacillus casei (1%) and fermented balsam extract after 3 days fermentation and G was Lactobacillus casei (5% Extract; H is a fermented chestnut extract after 3 days fermentation with Lactobacillus casei (10%); I is a fermented chestnut extract after 6 days fermentation with Lactobacillus casei (0%); J is a fermented chestnut extract after 6 days fermentation with Lactobacillus casei (1%); K is Lactobacillus casei (5%) and fermented after 6 days of fermentation; L is Lactobacillus casei (10%) and fermented after 6 days of fermentation; AA: Ascorbic acid, and the result is the mean (means) SD of triplicate);
Figure 8 shows the antimicrobial activity of Candida albicans of the fermented Blytheus extract (wherein A is Lactobacillus casei (0%) after 1 day of fermentation; B is Lactobacillus casei (1%), fermented chestnut extract after 1 day fermentation, C is Lactobacillus casei (5%) fermented after fermentation for 1 day, D is Lactobacillus casei (10%) fermented after 1 day fermentation; E is Lactobacillus casei (0%) and fermented after 3 days of fermentation; F is a fermented chestnut extract after 3 days fermentation with Lactobacillus casei (1%), G is fermented chestnut extract after 3 days fermentation with Lactobacillus casei (5%); H is a fermented chestnut extract after 3 days fermentation with Lactobacillus casei (10%); I is a fermented chestnut extract after 6 days fermentation with Lactobacillus casei (0%); J is a fermented chestnut extract after 6 days fermentation with Lactobacillus casei (1%); K is Lactobacillus casei (5%) and fermented after 6 days of fermentation; L is Lactobacillus casei (10%) and fermented after 6 days of fermentation; AA: Ascorbic acid, and the result is the mean (means) SD of triplicate);
Figure 9 shows the antimicrobial activity of Propionibacterium acnes of the fermented Bentoncus extract (wherein A is Lactobacillus < RTI ID = 0.0 > casei (0%) after 1 day of fermentation; B is a fermented chestnut extract of Lactobacillus casei (1%) after 1 day fermentation, C is fermented chestnut extract after 1 day fermentation with Lactobacillus casei (5%) and D is fermented Bacterium after 1 day fermentation with Lactobacillus casei (10% E is Lactobacillus casei (0%), fermented after 3 days fermentation, and F is Lactobacillus casei (1%) after fermentation for 3 days; G is a fermented chestnut extract after 3 days fermentation with Lactobacillus casei (5%); H is a fermented chestnut extract after 3 days fermentation with Lactobacillus casei (10%); I is a fermented chestnut extract after 6 days fermentation with Lactobacillus casei (0%); J is a fermented chestnut extract after 6 days fermentation with Lactobacillus casei (1%); K is Lactobacillus casei (5%) and fermented after 6 days of fermentation; L is Lactobacillus casei (10%) and fermented after 6 days of fermentation; AA: Ascorbic acid, and the result is the mean (means) SD of triplicate);
FIG. 10 shows the astringent activity of the fermented chestnut extract (where A is Lactobacillus casei (0%) and fermented Bacterium extract after 1 day fermentation; B is Lactobacillus casei (1% and; C is Lactobacillus casei (5%) and the fermentation sticker extract after 1 day fermentation; D is Lactobacillus casei (10%), with a fermentation sticker extract after 1 day fermentation; E is 3 days fermentation with Lactobacillus casei (0%) F is Lactobacillus casei (1%), fermented chestnut extract after 3 days fermentation, G is Lactobacillus casei (5%) fermented after 3 days fermentation and H is Lactobacillus casei (10% I is Lactobacillus casei (0%) after fermentation for 6 days, J is Lactobacillus casei (1%) after fermentation for 6 days and K is Lactobacillus casei (5%). After 6 days fermentation, L is Lactobacillus casei (10%), fermented chestnut extract after 6 days of fermentation; AA: Ascorbic acid, and the result is the means (± SD) of triplicate.

Below, The present invention will be described in detail by the following examples and experimental examples.

However, the following examples and experimental examples are illustrative of the present invention, and the content of the present invention is not limited by the following examples and experimental examples.

Example 1. Preparation of fermented chestnut extract

1.1. Plant resources

The chestnut used in this experiment was collected from Chestnut Wilderness in Daebyeong - myeon, Hapcheon, Gyeongnam, and used as experimental material. The collected chestnut was washed, pulverized and powdered, and stored at room temperature.

1.2. Setting fermentation conditions

In order to establish the fermentation condition, the experiment was conducted by two methods of extracting the supernatant and the precipitate of the liquid fermentation product.

1.3. Culture and inoculation of Starter

Lactobacillus used as a starter for the fermentation of Bacchus legume casei is a mixed liquid medium (Sucrose 22.0 g / l, Glucose 5.0 g / l, Soypeptone 11.0 g / l, Yeast extract 5.0 g / l, CH 3 COONa 2.0 g / l, K 2 HPO 4 0.2 g / l, MgCl 2 0.02 g / l).

1.4. Establish optimal extraction conditions

The antioxidant activity of the supernatant and the precipitate extract of liquid fermented product was determined by using the precipitate extract in consideration of the fixed experimental variables and the simplicity of mass production.

(Sucrose 22.0 g / l, Glucose 5.0 g / l, Soypeptone 11.0 g / l, Yeast extract 5.0 g / l, CH ₃ COONa 2.0 g / l, K ₂ HPO ₄ 0.2 g / l, MgCl ₂ 0.02 g / l) was added and the mixture was adjusted to pH 6.00 and sterilized. Then strain (lactic acid bacteria: Lactobacillus casei, ATCC 393) was inoculated to a 0, 1, 5, 10% (v / v) was fermented in 1, 3 and 6 days 35 ℃.

1.5. Fermented extract

After each fermentation was completed, the fermented chestnut was added with 10% of 80% ethanol and extracted for 4 days at room temperature. The supernatant and precipitate were separated and extracted three times. The supernatant and the precipitate were separated by filtration, The fermentation broth of the present invention was obtained by freeze-drying, and the fermented extract was stored in a refrigerated room at 4 ° C for use as a sample of the present invention.

Example 2. Fermentation and Extraction Condition Selection Experiment

2.1. pH Measure

The pH was measured using a pH meter from Thermo (Orion 3-Star, Thermo scientific, Singapore). Before measurement, the glass electrode was preliminarily immersed in basic buffer or distilled water for several hours, and the pH meter was connected to a power source for more than 10 minutes. The detector was washed with water and lightly wiped off.

2.2. Fermented Viable cell count  And pH Change of

The fermentation broths of 0, 1, 5, and 10% were mixed with 10 times by weight of mixed liquid medium and the fermented broths were fermented at 0, 1, 3, and 6 days. The pH was 5.00 and there was no change. The pH of 5, 10% inoculated continuously decreased with time.

In the case of fermentation for sediment, pH, viable cell counts were measured at 1, 3, 4, and 7 days and showed similar pattern to 5% fermentation group. (See Fig. 1)

2.3. Fermented chestnut extract Viable cell count  And pH Change of

The mixed culture broth of 10 times by weight was mixed with chestnut, and fermented for 1, 3, and 6 days after 1, 5, and 10% fermentation. As the inoculum size increased, the pH gradually decreased with time, but there was no significant change in bacterial growth. (See Fig. 2)

2.4. Yield of fermented chestnut extract

The yield of 80% ethanol extract of fermented Blyth was as follows. The yields were higher in the inoculum culture media than in the non - fermentation culture, and the yields were similar according to the fermentation days. Among them, the yield of the fermentation group of 1-day fermentation inoculated with 10% of the culture was the highest at 24.12%, and the yield was over 20% at all during 6 days of fermentation (see Table 1).

Yield rate of fermentation by Lactobacillus casei in chestnut bur . Inoculation (%) Yield rate 1 Day 0% 20.16% One% 21.44% 5% 19.64% 10% 24.12% 3 Day 0% 16.28% One% 19.80% 5% 19.32% 10% 18.82% 6 Day 0% 19.28% One% 20.80% 5% 20.16% 10% 22.00%

Experimental Example 1. Experiment of wrinkle-improving effect

1-1. Elastase ( Elastase ) Inhibition activity measurement

In order to test the elastase inhibitory activity of the samples obtained in the examples, Cannell et al. (Cannell RJP, Kellan SJ, Owsians AM and Walker JM. (1988) Results of a large scale screen of microalgae for the production of protease inhibitors. Planta Media . 54 (1), 10-14]

0.5 ml of 0.5 ml of porcine pancreas elastase (2.5 U / ml, Sigma E1250) dissolved in 50 mM tris-HCl buffer (pH 8.6) was added to each well and 0.5 ml of 50 mM tris-HCl N-succinyl- (L-Ala) 3-p-nitroanilide Sigma S4760 (0.5 mg / ml) was added to the substrate for 20 minutes and the amount of p-nitroanilide produced from the substrate was measured at 405 nm Respectively. Elastase inhibitory activity was expressed as the absorbance reduction rate of the sample solution with or without the addition of the sample solution.

As a result of this experiment, Elastase is a non - specific hydrolytic enzyme capable of degrading collagen, another important substrate protein. In the dermis of skin, collagen and elastin related to skin elasticity form a network structure. Elastase is known to be the main enzyme of wrinkle formation because elastin is broken down by elastase and binding of the network of the skin is broken. Elastase inhibitors have been shown to improve skin wrinkles, and ursolic acid has been used as an elastase inhibitor. It is one of the leukocyte granule enzymes that decompose the elastin in the body. The activity of enzymes in abnormal tissues is extremely high, which causes direct loss of tissue wrinkles and loss of elasticity.

The elastase inhibitory activity associated with wrinkle formation is shown in FIG. The extracts of fermented chestnut extract showed 36.2%, 51.7% and 94.8%, respectively, of elastase inhibitory activity similar to that of ursolic acid, which was used as control in the 100, 500 and 1,000 ug / Respectively.

1-2. Collagenase ( Collagenase ) Inhibition activity measurement

In order to test the collagenase inhibitory activity of the samples obtained in the examples, Van Wart (Van Wart) and the like were applied to the experiment as follows. [Van Wart HE, Steinbrink DR (1981), A continuous spectrophotometric assay for Clostridium histolyticum collagenase. Anal . Biochem ., 113 (2): 356-365.).

The reaction mixture was added with 4 mM CaCl ₂ in 0.1 M tris-HCl buffer (pH 7.5) to obtain 0.25 g of a solution of 4-phenylazobenzyloxycarbonyl-Pro-Leu-Gly-Pro-D-Arg (Sigma P8383 0.3 mg / ml and 0.1 ml of the sample solution, 0.15 ml of collagenase (Sigma C0130 0.2 mg / ml) was added. After standing at room temperature for 20 minutes, the reaction was stopped by adding 0.5 ml of 6% citric acid. And the absorbance at 320 nm was measured. Collagenase inhibitory activity was expressed as the absorbance reduction ratio of the sample solution and the non - added sample.

Most of the collagen is present in the dermis of the skin and accounts for about 70 to 80% of the dry weight of the skin. It plays the role of supporting the skin occupying most of the extracellular matrix. However, degradation of collagen is accelerated by extrinsic factors such as decrease of collagen biosynthesis due to internal factors such as decrease of cell activity due to natural aging, increase of stress due to various harmful environments, and increase of active oxygen species by sunlight And the skin substrate is destroyed to form wrinkles. Such collagen is reduced by aging and photoaging by ultraviolet irradiation,

The collagenase inhibitory activity of the fermented chestnut extract was measured as shown in FIG. 4 because it was known to be closely related to the wrinkling of the skin.

The collagenase inhibitory activity of fermented chestnut bark was measured by the extraction conditions. As a result, the culture broth extract showed 96.0% collagenase inhibitory activity at the concentration of 1,000 ug / ml for 6 days after 5% inoculation. It was confirmed that the collagenase inhibitory activity of fermented chestnut extract was superior to that of ursolric acid.

Experimental Example 2. Antibacterial Effect Verification Experiment

(An BJ, Kwak JH, Son JH, Park JM, Lee JY, Jo C, et al.) In order to confirm the antibacterial effect of the samples obtained in the above Examples. , Byun MW (2004), Biological and anti-microbial activity of irradiated green tea polyphenols. Food Chemistry., 88: 549555.)

2-1. Bacterial culture

Candida YM broth (YMB) was used as a liquid medium for the cultivation of albicans (KCTC 7965), Escherichia Nutrient broth (NB) was used as a liquid medium for E. coli (KCTC 1039) and Staphylococcus epidermidis (KCTC 1917), tryptic soy broth (TSB) was used as a liquid medium for Staphylococcus aureus (KCTC 1621), Propionibacterium acnes KCTC 3314) used GAM broth (GB). The solid medium was used in this experiment by adding 2% agar to the liquid medium. Propionibacterium acnes (KCTC 3314) was incubated in CO ₂ incubator and other strains were incubated at 37 ° C in BOD incubator.

2-2. Growth Inhibition circle ( Clear zone ) Measure

The antimicrobial activity was measured by paper disc method. Namely, each strain cultured on a plate culture medium was inoculated into 10 ml of a liquid culture medium and incubated for 3-6 hours in 0.1 ml of a liquid culture medium. After culturing for 18 to 24 hours in a liquid culture medium, The cells were inoculated at a dose of about 1.7 × 10 ^-6 to 7.2 × 10 ⁷ cfu / ml per medium and uniformly plated on a sterilized cotton swab. After sterilized filter paper discs (Tokyo, 8mm, Japan) were placed on a solid plate medium, the specimens were absorbed at concentrations of 0.05ml / disc and incubated at 37 ℃ for 18-24 hours to obtain clear zone Diameter was measured.

To investigate the antimicrobial effect of fermented chestnut extract, Candida albicans , Escherichia coli , Staphylococcus epidermidis , Staphylococcus aureus , and Propionibacterium acnes. The results are shown in Tables 2 to 6 and 5 to 9. C. albicans, S. s aureus, and P. acnes showed no antimicrobial activity before and after fermentation. In the case of E. coli , the fermented extracts inoculated at 10% in 1, 3, and 6 days at the concentration of 2.0 mg / disc were 19.0 mm, 18.5 mm and 15.0 mm, respectively. The fermented extracts of unfermented chestnut extract were 16.0 mm, 15.0 mm and 14.5 mm , Indicating that the antimicrobial effect against E. coli was high during the fermentation, but the antimicrobial effect was not improved by the fermentation time.

In the case of S. epidermidis , the fermented extracts of 5% inoculated at 1, 3, and 6 days were 32.0, 31.0, and 13.0 mm, respectively, at 2.0 mg / mm, respectively. The fermentation efficiency of S. epidermidis was higher than that of before fermentation. The antimicrobial effect of 5% inoculated on 3 days was 18.0 mm at 0.5 mg / disc and 26.0 mm at 1.0 mg / disc. The fermented extracts showed the highest antimicrobial activity when fermented for 3 days.

Antimicrobial activity of Escherichia coli . Concentrations
Sample 0.1 mg / disc 0.5 mg / disc 1.0 mg / disc 2.0 mg / disc A - ^a 13.0 ^b 16.0 16.0 B - 13.5 15.0 16.5 C - 12.0 15.0 17.0 D - 12.5 17.0 19.0 E - 11.0 13.0 14.5 F - 12.0 14.0 15.0 G - 12.0 13.5 17.5 H - 12.0 14.0 18.5 I - 12.5 14.5 15.0 J - 12.0 14.5 16.0 K - 12.5 14.5 14.5 L - 12.0 13.5 15.0

Antimicrobial activity of Staphylococcus epidermidis Concentrations
Sample 0.1 mg / disc 0.5 mg / disc 1.0 mg / disc 2.0 mg / disc A - ^a - 18.0 ^b 22.0 B - - 24.0 25.0 C - - 15.0 32.0 D - - 24.0 26.0 E - - 12.0 26.0 F - - - 20.0 G - 18.0 26.0 31.0 H - - - 18.0 I - - 11.0 21.0 J - - - 13.0 K - - - 13.0 L - - - 12.0

Antimicrobial activity of Staphylococcus aureus Concentrations
Sample 0.1 mg / disc 0.5 mg / disc 1.0 mg / disc 2.0 mg / disc A - ^a - - - B - - - - C - - - - D - - - - E - - - - F - - - - G - - - - H - - - - I - - - - J - - - - K - - - - L - - - -

Antimicrobial activity of Candida albicans . Concentrations
Sample 0.1 mg / disc 0.5 mg / disc 1.0 mg / disc 2.0 mg / disc A - ^a - - - B - - - - C - - - - D - - - - E - - - - F - - - - G - - - - H - - - - I - - - - J - - - - K - - - - L - - - -

Antimicrobial activity of Propionibacterium Acnes . Concentrations
Sample 0.1 mg / disc 0.5 mg / disc 1.0 mg / disc 2.0 mg / disc A - ^a - - - B - - - - C - - - - D - - - - E - - - - F - - - - G - - - - H - - - - I - - - - J - - - - K - - - - L - - - -

Experimental Example 3. Convergence Effect Verification Experiment

In order to confirm the convergence effect of the samples obtained in the above examples, the measurement was performed according to the astringent assay method described in the literature (Lee, JT, Jeong, YS and An, BJ: Physiological activity of Salicornia herbacea and its application for cosmetic Materials. Kor J. Herbology, 17, 51-60, 2002.)

Using a blood protein (hemoglobin) similar to skin protein, each sample solution and hemoglobin solution were mixed in a 1: 1 mixture by shaking in a centrifuge tube, centrifuged at 1,500 rpm for 3 minutes, and absorbance was measured at 576 nm. The astringent activity measurement was expressed as the absorbance reduction rate of the sample solution addition group and the no addition group.

The skin protein binds to the polymeric flavonoids polyohenols to form crosslinks, causing the skin to contract and converge. Convergence means basically wrinkled or funky. Convergent agent has a function to shrink skin and mucosal blood vessels, and has an effect of inhibiting secretion of mucus by interrupting cell gap and lymphatic gap. In addition, since astringent agent has a property of binding to protein, it can generally judge degree of convergence effect according to degree of binding of hemoglobin protein to extract. Such convergent action may be said to have an effect of forming an insoluble film on the surface of skin and mucous membranes by external use or contents and consequently protecting the locality or densifying the tissue to reduce the permeability of the cell membrane.

The astringent activity of the fermented chestnut extract was measured as shown in Fig. The culture broth extract showed 12.2% activity for 3 days after 10% strain inoculation at 10 ug / ml.

Statistical processing

Experimental results were expressed as mean ± SD after 3 repeated measurements. Statistical analysis was performed using a SAS program (SAS Institue, Cary, NC, USA). Duncan's multiple test was performed and the correlation was analyzed.

Hereinafter, formulations of cream, massage cream, lotion, skin lotion, essence, pack, and cleansing foam are exemplified as the formulation examples of the present invention, but the formulations including the cosmetic composition of the present invention are not limited thereto.

Formulation Example  1. Cream composition

The oil phase and water phase are heated to 75 ° C and cooled to room temperature.

Formulation Example  2. Massage Cream  Composition

The oil phase and water phase are mixed by heating at 75 DEG C and then cooled to room temperature.

Formulation Example  3. lotion composition

The oil phase and water phase are mixed and emulsified by heating at 75 ° C and then cooled to room temperature.

Formulation Example  4. Skin lotion composition

   The water phase and the ethanol phase are respectively prepared and mixed and then filtered.

Formulation Example  5. Essence composition

The water phase and the ethanol phase are respectively prepared and mixed and then filtered.

Formulation Example  6. Pack composition

The water phase and the ethanol phase are dispersively dissolved and mixed, and then cooled to room temperature.

Formulation Example  7. Cleansing Foam  Composition

The water phase and the oil phase are dispersed and dissolved, mixed and sieved, and then cooled to room temperature.

Claims (10)

A composition for external application for skin for the treatment and prevention of wrinkle improvement and bacterial skin diseases containing fermented chestnut extract as an active ingredient. The bamboo shoot according to claim 1, wherein the bamboo shoot is selected from the group consisting of Castanea crenata, Castanea mollissima, Castanea davidii, China, Castanea henryi, Castanea seguinii, Castanea dentata, Castanea pumila, Castanea alnifolia, Castanea ashei, Castanea floridana, Castanea paupispina, or Castanea spp. Castanea sativa < / RTI > chestnut. The dermatological pharmaceutical composition according to claim 1, wherein the fermented chestnut extract is a fermented balsam supernatant or a precipitate extract. The method of claim 1 wherein said fermented chestnut extract is selected from the group consisting of water, ethanol, methanol, propanol, butanol, acetone, ethyl acetate, hexane, butylene glycol, propylene glycol, hydrolyzed butylene glycol, Lt; RTI ID = 0.0 > selected < / RTI > solvent. The method according to claim 1, wherein the fermentation is performed by inoculating the activated lactic acid bacteria activated through liquid culture to a volume of 1-30% (v / v) of the weight of the sample, Wherein the composition is cultured. The method of claim 5, wherein the liquid culture is Sucrose 10 to 30.0 g / l, Glucose 1 to 10.0 g / l, Soypeptone 3 to 20.0 g / l, Yeast extract 1 to _{100 g / l, CH 3 COONa} 1 to 5.0 g / l, K ₂ HPO ₄ 0.1 to 0.6 g / l, and MgCl ₂ 0.01 to 0.05 g / l in the range of pH 4.00 to 7.00 and sterilized to perform fermentation. Composition. The composition according to claim 1, wherein the bacterial skin disease is acne, oral infection, genital infection, skin rash, otitis media, or cystitis. The dermatological pharmaceutical composition according to claim 1, wherein the pharmaceutical composition is a cream, a gel, a patch, a spray, an ointment, a warning agent, a lotion, a liniment, a pasta or a cataplasma. A cosmetic composition for improving and preventing wrinkles and bacterial skin diseases containing fermented chestnut extract as an active ingredient. The cosmetic composition according to claim 9, wherein the cosmetic composition is a formulation of lotion, skin, lotion, nutritional lotion, nutritional cream, massage cream, essence, and pack.

Images